Pimavanserin (Nuplazid®) for Parkinson’s disease psychosis

By Rajnish Mago, MD (bio) Pimavanserin is the only medication approved (in 2016) by the US Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. One phase II and two phase III clinical trials showed trends for pimavanserin to be efficacious but the results were not statistically…